Draxis deal

Draxis Health Inc. (DRAXF) DRAXF (Toronto) acquired from Somerset Pharmaceuticals Inc.(Tampa) the exclusive Canadian marketing rights to the osteoporosis drug Ipriflavone. Ipriflavone is in Phase II ...